Mesothelioma: Peritoneal, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology.


Journal

Journal of the National Comprehensive Cancer Network : JNCCN
ISSN: 1540-1413
Titre abrégé: J Natl Compr Canc Netw
Pays: United States
ID NLM: 101162515

Informations de publication

Date de publication:
09 2023
Historique:
medline: 8 9 2023
pubmed: 7 9 2023
entrez: 6 9 2023
Statut: ppublish

Résumé

Mesothelioma is a rare cancer originating in mesothelial surfaces of the peritoneum, pleura, and other sites. These NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) focus on peritoneal mesothelioma (PeM). The NCCN Guidelines for PeM provide recommendations for workup, diagnosis, and treatment of primary as well as previously treated PeM. The diagnosis of PeM may be delayed because PeM mimics other diseases and conditions and because the disease is so rare. The pathology section was recently updated to include new information about markers used to identify mesothelioma, which is difficult to diagnose. The term "malignant" is no longer used to classify mesotheliomas, because all mesotheliomas are now defined as malignant.

Identifiants

pubmed: 37673108
doi: 10.6004/jnccn.2023.0045
doi:

Types de publication

Journal Article Practice Guideline

Langues

eng

Sous-ensembles de citation

IM

Pagination

961-979

Auteurs

David S Ettinger (DS)

The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.

Douglas E Wood (DE)

Fred Hutchinson Cancer Center.

James Stevenson (J)

Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Centerand Cleveland Clinic Taussig Cancer Institute.

Dara L Aisner (DL)

University of Colorado Cancer Center.

Wallace Akerley (W)

Huntsman Cancer Institute at the University of Utah.

Jessica R Bauman (JR)

Fox Chase Cancer Center.

Ankit Bharat (A)

Robert H. Lurie Comprehensive Cancer Center of Northwestern University.

Debora S Bruno (DS)

Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Centerand Cleveland Clinic Taussig Cancer Institute.

Joe Y Chang (JY)

The University of Texas MD Anderson Cancer Center.

Lucian R Chirieac (LR)

Dana-Farber/Brigham and Women's Cancer Center.

Malcolm DeCamp (M)

University of Wisconsin Carbone Cancer Center.

Thomas J Dilling (TJ)

Moffitt Cancer Center.

Jonathan Dowell (J)

UT Southwestern Simmons Comprehensive Cancer Center.

Gregory A Durm (GA)

Indiana University Melvin and Bren Simon Comprehensive Cancer Center.

Scott Gettinger (S)

Yale Cancer Center/Smilow Cancer Hospital.

Travis E Grotz (TE)

Mayo Clinic Cancer Center.

Matthew A Gubens (MA)

UCSF Helen Diller Family Comprehensive Cancer Center.

Aparna Hegde (A)

O'Neal Comprehensive Cancer Center at UAB.

Rudy P Lackner (RP)

Fred & Pamela Buffett Cancer Center.

Michael Lanuti (M)

Mass General Cancer Center.

Jules Lin (J)

University of Michigan Rogel Cancer Center.

Billy W Loo (BW)

Stanford Cancer Institute.

Christine M Lovly (CM)

Vanderbilt-Ingram Cancer Center.

Fabien Maldonado (F)

Vanderbilt-Ingram Cancer Center.

Erminia Massarelli (E)

City of Hope National Medical Center.

Daniel Morgensztern (D)

Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine.

Trey C Mullikin (TC)

Duke Cancer Institute.

Thomas Ng (T)

The University of Tennessee Health Science Center.

Gregory A Otterson (GA)

The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute.

Sandip P Patel (SP)

UC San Diego Moores Cancer Center.

Tejas Patil (T)

University of Colorado Cancer Center.

Patricio M Polanco (PM)

UT Southwestern Simmons Comprehensive Cancer Center.

Gregory J Riely (GJ)

Memorial Sloan Kettering Cancer Center.

Jonathan Riess (J)

UC Davis Comprehensive Cancer Center.

Theresa A Shapiro (TA)

The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.

Aditi P Singh (AP)

Abramson Cancer Center at the University of Pennsylvania.

Alda Tam (A)

The University of Texas MD Anderson Cancer Center.

Tawee Tanvetyanon (T)

Moffitt Cancer Center.

Jane Yanagawa (J)

UCLA Jonsson Comprehensive Cancer Center.

Stephen C Yang (SC)

The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.

Edwin Yau (E)

Roswell Park Comprehensive Cancer Center.

Kristina M Gregory (KM)

National Comprehensive Cancer Network.

Miranda Hughes (M)

National Comprehensive Cancer Network.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH